ARROWHEAD PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Revenue
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Increase (Decrease) in Deferred Revenue of -$5.27 million for the 12-month period ending 2018-09-30, per its 10-K filed 2018-12-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-12-11
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was -$942.60K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$621.80K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$310.00K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$3.39M, a 113.23% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2018 was -$5.27M, a 3435.30% decline from fiscal 2017.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2017 was $157.98K, a 96.84% decline from fiscal 2016.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2016 was $5.00M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$942.60K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | -$1.56M derived: sum of 2 quarters · filed 2018-12-11 | -$1.87M derived: sum of 3 quarters · filed 2018-12-11 | -$5.27M 10-K · filed 2018-12-11 |
| 2018-06-30 | -$621.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07 | -$931.80K derived: sum of 2 quarters · filed 2018-08-07 | -$4.33M 10-Q · filed 2018-08-07 | -$12.96M derived: sum of 4 quarters · filed 2018-12-11 |
| 2018-03-31 | -$310.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08 | -$3.70M 10-Q · filed 2018-05-08 | -$12.34M derived: sum of 3 quarters · filed 2018-12-11 | -$20.85M derived: sum of 4 quarters · filed 2018-12-11 |
| 2017-12-31 | -$3.39M 10-Q · filed 2018-02-09 | -$12.03M derived: sum of 2 quarters · filed 2018-12-11 | -$20.54M derived: sum of 3 quarters · filed 2018-12-11 | -$28.89M derived: sum of 4 quarters · filed 2018-12-11 |
| 2017-09-30 | -$8.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | -$17.15M derived: sum of 2 quarters · filed 2018-12-11 | -$25.49M derived: sum of 3 quarters · filed 2018-12-11 | $157.98K 10-K · filed 2018-12-11 |
| 2017-06-30 | -$8.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07 | -$16.86M derived: sum of 2 quarters · filed 2018-08-07 | $8.80M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | -$8.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08 | $17.31M 10-Q · filed 2018-05-08 | ||
| 2016-12-31 | $25.65M 10-Q · filed 2018-02-09 | |||
| 2016-09-30 | $5.00M 10-K · filed 2018-12-11 | |||
| 2016-03-31 | -$37.50K 10-Q · filed 2017-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |